trial

Evaluation of Stroop Effect in Patients With Schizophrenia

NCTId NCT03163706
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 80 (estimated)
Sponsored by University Hospital, Clermont-Ferrand
Primary completion 2018-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
80 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2016-09-21
Primary completion
2018-10
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Modified Stroop effect

Sponsors

University Hospital, Clermont-FerrandLead Sponsor
Université d'AuvergneCollaborator

Sites

1 total
Clermont-Ferrand, France

Facts & assertions

4 sourced
Enrollment
80
Phase
NA
Primary Completion Date
2018-10
Status
UNKNOWN
relationships
The graph out of here
drug
Modified Stroop effect
drug
lead_sponsor
University Hospital, Clermont-Ferrand
company
collaborator
Université d'Auvergne
company
indication
Schizophrenia
indication
Schizophrenia
indication